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SURGICALTECHNIQUESRobot-assisted septal myectomy for hypertrophic cardiomyopathy
with left ventricular outflow tract obstructionZainKhalpey,MD,PhD,MRCS (Eng),a LevKorovin,BS,aW.RandolphChitwood, Jr,MD,FACS, FRCS,b and
Robert Poston, MD,a Tucson, Ariz, and Greenville, NCHypertrophic cardiomyopathy is a relatively common
disease caused by genetic mutations that disrupt the sarco-
mere components. Although frequent in younger patients, it
can present from infancy to old age. Its natural history can
include sudden cardiac death, arrhythmias, and heart fail-
ure.1 Severe heart failure symptoms can result from left
ventricular outflow tract (LVOT) obstruction, with or
without systolic anterior motion of the mitral valve appa-
ratus. For patients with LVOTobstruction, the outflow tract
pressure gradient can be reduced using interventional tech-
niques that have included surgical septal myectomy and
alcohol septal ablation. According to a recent meta-
analysis, septal myectomy has been superior in terms of
reducing the gradient and preventing persistent conduction
abnormalities.2
The initial reports of myectomy for symptomatic patients
with LVOTobstruction described septal exposure by way of
a left atriotomy and takedown of the anterior mitral leaflet.
Given the challenge of septal visualization, this traditional
approach was abandoned for the current standard, the
Morrow procedure, which involves access to the ventricular
septum by way of an aortotomy across the aortic valve. Two
major limitations of both these procedures have been the
required sternotomy and associated prolonged postopera-
tive recovery.
Surgical robotics has been used to routinely access the
mitral valve by way of a left atriotomy. Therefore, a similar
approach could be used to reintroduce the transatrial, trans-
mitral approach to the hypertrophic septum. We have
described a septal myectomy performed with a less-
invasive, robot-assisted approach in a patient with recurrent
symptomatic LVOT obstruction who had previously under-
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The patient’s preoperative echocardiogram demonstrated
systolic anterior motion of the mitral valve chordate with an
LVOT gradient of 20 to 30 mm Hg that increased to 61 mm
Hg with the Valsalva maneuver. The maximum septal thick-
ness was measured at 16.5 mm using computed tomogra-
phy. Moreover, the patient had class III heart failure
symptoms despite maximal medical therapy.
After deflating the patient’s right lung, we inserted 3 ports
at the third, fifth, and seventh intercostal spaces. We docked
the robot to those ports using a topographic approach
similar to that described by Chitwood.3 After systemic hep-
arinization, we instituted cardiopulmonary bypass using
femoral artery and vein cannulation. With both lungs
deflated, we used robotic instruments to open and tack the
pericardium to the chest wall. We dissected Sondergaard’s
groove to separate the left and right atria and then induced
cardioplegia using ascending aorta cannulation in an ante-
grade manner.
Next, we incised the left atrium and inserted the left atrial
retractor. The mitral valve was normal on inspection. We
opened the anterior leaflet (Figure 1, A) and identified the
septum and aortic valve (Figure 1, B). The previously abla-
ted portion of the septum was clearly visible by the exten-
sive scarring. We removed 3 strips of the copiously
scarred ablated septum, which lacked normal myocardial
tissue (Figure 1, C). We reapproximated the anterior leaflet
with Gore-Tex 5-0 suture (W. L. Gore & Associates, Flag-
staff, Ariz) and then tested the valve for leakage.
Finally, we closed the left atrium, removed the cross-
clamp, and performed de-airing maneuvers. Initially, we
observed signs of a spontaneous rhythm; however, subse-
quently, complete heart block developed. Therefore, we
paced the patient ventricularly, using a pacing wire to the
inferior aspect of the right ventricle. The LVOT gradient
was reduced; we no longer observed systolic anterior mo-
tion. The patient was successfully weaned off cardiopulmo-
nary bypass. Postoperatively, the patient required
placement of a permanent pacemaker for persistent com-
plete heart block; however, she had returned to a normal si-
nus rhythm 1 month postoperatively. The immediate
postoperative echocardiogram showed an LVOT gradient
of 15 mm Hg. At her 4-month follow-up visit, we noted
no significant intracavitary gradient. The postoperative
septal thickness was 0.98 cm, and the distance between
the mitral–septal contact point and the aortic annulus was
1.0 cm.gery c May 2014
FIGURE 1. A, Opening the mitral valve anterior leaflet. Curved robotic scissors were used to incise the anterior leaflet, proceeding counterclockwise in a
radial fashion from the right fibrous trigone to the left fibrous trigone. B, Exposure of the interventricular septum and aortic valve through the mobilized
mitral valve anterior leaflet. C, Resection of the previously ablated fibrotic interventricular septum. The rectangular resected tissue was extended clockwise
from near the left fibrous trigone to the nadir of the right coronary cusp.
Surgical TechniquesDISCUSSION
The Morrow procedure uses a midline sternotomy, with
the left ventricle and septum accessed by the aortic valve
through a vertical aortotomy.4 The potential limitations of
the procedure include small, but persistent, risks of an aor-
totomy (eg, postoperative bleeding, aortic dissection), diffi-
culties with visualizing the surgical anatomy, and the risk of
aortic valve damage (approximately 5% rate of moderate
aortic regurgitation postoperatively5).
A robotic approach using the left atrium and across the
mitral valve is an alternative and more direct route to the
ventricular septum that can circumvent the limitations of
the standard transaortic approach. The required robotic
manipulation of the mitral valve for left ventricular septum
access seems less risky than the transaortic route across the
often friable aortic valve for provoking valvular damage.
Although additional studies are needed to evaluate the
frequency of associated complications, our robot-assistedFrom the Section of Cardiac Surgery, Department of Cardiovascular Disease,
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procedure.
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cardiomyopathy with abnormal papillary muscle morphology:
Septal myectomy plus papillary muscle repositioningMarianna Redaelli, MD, Camillo Luca Poloni, MD, Samuele Bichi, MD, and Giampiero Esposito, MD,
Bergamo, ItalyHypertrophic obstructive cardiomyopathy (HOCM) is
considered a primary disease of cardiac muscle characte-
rized by a diverse morphologic and clinical spectrum.1,2
The physiopathology of hypertrophic cardiomyopathy
has been clarified by advanced echocardiographic and
magnetic resonance imaging technologies (cardiac
magnetic resonance imaging). With these advances,
surgical management has also evolved, because the role
of the mitral valve and subvalvular structures in causingdiovascular Surgery c Volume 147, Number 5 1709
